• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Study: Patient Portals Improved Medication Adherence for Diabetic Patients

by Jasmine Pennic 01/07/2014 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Diabetic patients who used patient portals to refill medications increased their medication adherence and improved their cholesterol levels, according to a new study in the journal Medical Care. According to the study, medication non-adherence and poorly controlled cholesterol declined by 6 percent among exclusive users of the online refill function, compared to occasional users or non-users, PRNewswire reports.

The results are promising given the mixed commentary surrounding the effectiveness of using patient portals as a meaningful tool for patient engagement.

Background

The study is part of a body of research to better understand how Kaiser Permanente’s online patient portals can improve care.

The National Institutes of Health funded researchers from Kaiser Permanente and the University of California, San Francisco Medical School to follow 17,760 patients with diabetes who received care from Kaiser Permanente in Northern California between January 2006 and December 2010. All patients were registered users of Kaiser Permanente’s personal health record, My Health Manager

Methodology

Patients were divided into three groups based on their use of the portal to order refills of their cholesterol-lowering medications:

  • the control group included those who never used the online refill function
  • “occasional users,” who requested medication refills through the Kaiser Permanente patient portal at least once (but not always)
  • “exclusive users” who requested all of their refills through the patient portal.

The cholesterol-lowering medications in the study are widely prescribed for patients with diabetes.

The average age of the diabetic patients was 62, and 40 percent were non-white minorities.  The diabetes patients studied had an average of more than six chronically used medications and 11 outpatient visits per year.

“This research is an important step in understanding the benefits of portals beyond convenience,” said lead author Urmimala Sarkar, MD, an assistant professor at University of California San Francisco. “Given the clear connection between medication adherence and improved health outcomes, this study provides insight into how online portals may improve health outcomes.”

Stage 2 of the Meaningful Use requires that at least 5 percent of patients view, download, and transmit their health information and send a secure electronic message to their provider.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |